IndraLab

Statements



reach
"These points highlight the ubiquitin pathway as a promising target for the development of novel antimalarials.In this study, we used the RaPID selection technique to identify cyclic peptide inhibitors of PfUCHL3, a dual activity DUB/deneddylating enzyme of P. falciparum, the deadliest malaria parasite."